Shawn McKinney, MD
Surgical Oncology · New Orleans, LANPI 1497714786
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (53.2%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.4%. Reporting peaked in 2021 at $1,572 and has fallen 84.9% since, to $237 in 2025.
Across 61 payments — averaging $62.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biom'up France SAS$811
- Hologic Inc$574
- Medtronic$563
- Daiichi Sankyo Inc.$286
- Tempus AI, Inc$227
- AstraZeneca$158
- plus $1K from 21 others
What the payments were for
- Speaking & faculty fees$70018%
- Travel & lodging$1,04928%
- Food & beverage$2,01653%
- Education$271%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biom'up France SAS | 2 | $811 |
| Hologic Inc | 1 | $574 |
| Medtronic | 9 | $563 |
| Daiichi Sankyo Inc. | 4 | $286 |
| Tempus AI, Inc | 4 | $227 |
| AstraZeneca | 3 | $158 |
| Amgen | 7 | $144 |
| Gilead | 1 | $121 |
| Lilly USA, LLC | 1 | $97 |
| Puma Biotechnology, Inc. | 7 | $90 |
| Integra Lifesciences Corporation | 1 | $84 |
| Novartis | 4 | $83 |
| Hologic Sales And Service, LLC | 2 | $78 |
| Aroa Biosurgery Incorporated | 1 | $75 |
| Genentech, Inc. | 1 | $70 |
| Endomagnetics Ltd | 2 | $65 |
| Davol Inc. | 1 | $51 |
| Teleflex LLC | 1 | $38 |
| Eisai Inc. | 1 | $28 |
| Leica Microsystems Inc. | 1 | $27 |
| AbbVie | 1 | $25 |
| Stryker | 1 | $24 |
| Medela LLC | 1 | $20 |
| Bristol Myers Squibb | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
| KCI USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HemoBlast Bellows$811
- Localizer$574
- BioZorb$574
- TRIDENT SPECIMEN RADIOGRAPHY SYSTEM$574
- PlasmaBlade$375
- LYNPARZA$125
- Enhertu$123
- Trodelvy$121
How this compares
$3,792 in reported general payments places this provider in the 75th percentile of 26 surgical oncology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other surgical oncology in New Orleans
- Nathan BoltonNew Orleans$6K
- David PointerNew Orleans$4K
- Amy RivereNew Orleans$4K
- Omeed MoavenNew Orleans$3K
- Nicole WalkerNew Orleans$3K
- Mohamed ShamaNew Orleans$2K
- Saad Al AwwadNew Orleans$2K
- Russell BrownNew Orleans$2K
- Jane WeyNew Orleans$1K
- George FuhrmanNew Orleans$675
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.